"Virtual stent" - clinical evaluation and user experience of on-the-fly stent simulation in treatment of cerebral aneurysms.


Journal

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
ISSN: 2385-2011
Titre abrégé: Interv Neuroradiol
Pays: United States
ID NLM: 9602695

Informations de publication

Date de publication:
Oct 2022
Historique:
pubmed: 30 10 2021
medline: 28 9 2022
entrez: 29 10 2021
Statut: ppublish

Résumé

Predicting final stent position can be challenging when treating cerebral aneurysms. Third-Party software proved helpful in selecting proper stents in treatment planning. Recent angiographic systems provide basic stent simulation capabilities integrated in the post-processing software to simulate stent position. Goal of this analysis was to evaluate the simulation process and correlation with definite stent position. Thirty-three datasets with fusiform (n = 10) and saccular (n = 23) aneurysms, treated with stent or flow-diverter, were processed. A "virtual stent" of the same (nominal) size was simulated and its position was compared to the treatment result. Simulated length was rated in five grades (too short, shorter, equal, longer, too long), with regard to side-branches, anchoring zone etc. Simulation quality (centerline recognition/adherence to vessel margins) was rated in three grades (no, minor or major corrections required). Simulation was successful in 32/33 cases (97%), with one abortive attempt (3%). In 27/33 simulations (82%), there was no need for centerline refinement. Minor corrections were necessary in four and major corrections in two cases. Simulated nominal length was rated "equal" in 14/33 (42%) cases and "shorter" or "longer" - but within acceptable range - in each 9/33 (27%) cases. Basic stent simulation tools available with genuine angiographic workplace software can provide good simulation capabilities without need for third-party equipment. They can facilitate treatment planning and help to avoid shortage of devices. Yet, lack of calculation of foreshortening in large vessel diameters leaves the user to rely on their experience to account for device-specific properties.

Sections du résumé

BACKGROUND BACKGROUND
Predicting final stent position can be challenging when treating cerebral aneurysms. Third-Party software proved helpful in selecting proper stents in treatment planning. Recent angiographic systems provide basic stent simulation capabilities integrated in the post-processing software to simulate stent position. Goal of this analysis was to evaluate the simulation process and correlation with definite stent position.
MATERIALS AND METHODS METHODS
Thirty-three datasets with fusiform (n = 10) and saccular (n = 23) aneurysms, treated with stent or flow-diverter, were processed. A "virtual stent" of the same (nominal) size was simulated and its position was compared to the treatment result. Simulated length was rated in five grades (too short, shorter, equal, longer, too long), with regard to side-branches, anchoring zone etc. Simulation quality (centerline recognition/adherence to vessel margins) was rated in three grades (no, minor or major corrections required).
RESULTS RESULTS
Simulation was successful in 32/33 cases (97%), with one abortive attempt (3%). In 27/33 simulations (82%), there was no need for centerline refinement. Minor corrections were necessary in four and major corrections in two cases. Simulated nominal length was rated "equal" in 14/33 (42%) cases and "shorter" or "longer" - but within acceptable range - in each 9/33 (27%) cases.
CONCLUSION CONCLUSIONS
Basic stent simulation tools available with genuine angiographic workplace software can provide good simulation capabilities without need for third-party equipment. They can facilitate treatment planning and help to avoid shortage of devices. Yet, lack of calculation of foreshortening in large vessel diameters leaves the user to rely on their experience to account for device-specific properties.

Identifiants

pubmed: 34713749
doi: 10.1177/15910199211053131
pmc: PMC9511612
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

581-587

Références

AJNR Am J Neuroradiol. 2015 Sep;36(9):1728-34
pubmed: 25999412
J Neurointerv Surg. 2019 Jun;11(6):591-597
pubmed: 30674632
AJNR Am J Neuroradiol. 2013 Oct;34(10):1987-92
pubmed: 23639562
AJNR Am J Neuroradiol. 2012 Apr;33(4):649-54
pubmed: 22194381
AJNR Am J Neuroradiol. 2012 Oct;33(9):1657-62
pubmed: 22538075
J Neurointerv Surg. 2020 Oct;12(10):968-973
pubmed: 32111727
J Neurosurg. 2018 Nov 1;:1-7
pubmed: 30497172
AJNR Am J Neuroradiol. 2008 Aug;29(7):1405-8
pubmed: 18436611
Neurosurg Focus. 2017 Jun;42(6):E3
pubmed: 28565988
J Neurointerv Surg. 2011 Dec 1;3(4):340-3
pubmed: 21990459
Neurosurgery. 2017 Jan 01;80(1):40-48
pubmed: 28362885
AJNR Am J Neuroradiol. 2019 Mar;40(3):524-530
pubmed: 30733254
AJNR Am J Neuroradiol. 2005 Oct;26(9):2368-70
pubmed: 16219847
AJNR Am J Neuroradiol. 2008 Oct;29(9):1777-81
pubmed: 18719039
Neurointervention. 2017 Mar;12(1):31-39
pubmed: 28316867

Auteurs

Hannes Luecking (H)

Department of Neuroradiology, 9171University of Erlangen-Nuremberg, Erlangen, Germany.

Annette Birkhold (A)

42406Siemens Healthineers AG, Forchheim, Germany.

Philip Hoelter (P)

Department of Neuroradiology, 9171University of Erlangen-Nuremberg, Erlangen, Germany.

Stefan Lang (S)

Department of Neuroradiology, 9171University of Erlangen-Nuremberg, Erlangen, Germany.

Philipp Goelitz (P)

Department of Neuroradiology, 9171University of Erlangen-Nuremberg, Erlangen, Germany.

Manuel Schmidt (M)

Department of Neuroradiology, 9171University of Erlangen-Nuremberg, Erlangen, Germany.

Anne Mrochen (A)

Department of Neurology, 9171University of Erlangen-Nuremberg, Erlangen, Germany.

Sebastian Brandner (S)

Department of Neurosurgery, 9171University of Erlangen-Nuremberg, Erlangen, Germany.

Arnd Doerfler (A)

Department of Neuroradiology, 9171University of Erlangen-Nuremberg, Erlangen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH